virus use limit set host pathway infect metres bona fide antivirus target low likelihood viral resist identify salicylanilid niclosamid broad rang agent target acidic endosom approve human relmonth infect antineoplast effect mode action unknown show weak lipophil acid inhibit depend rhinovirus harv influenza virus structureact studi show efficacy endolysosom ph neutral coatrack acidic extracellular medium bypass entry block affect vascular https neutral coat vesicle synthetic liposom india proton carrier modeofact indeed protein target report demons physicochem interfere provide proof concept develop hostdirect antivirus 